Global TAVR market to hit $14.06b by 2035

Its expansion is driven by the rising prevalence of aortic stenosis.

The global transcatheter aortic valve replacement (TAVR) market is expected to reach $14.06b by 2035 at a compound annual growth rate of 6.9%, said Vantage Market Research.

The sector’s expansion is attributed to the rising prevalence of aortic stenosis, growing adoption of minimally invasive heart valve procedures, and increasing approvals for lower-risk patients.

Moreover, favourable reimbursement frameworks, technological developments in valve design and durability, and an increasing preference for shorter recovery times are driving market growth.

However, high procedure and device costs may limit accessibility in cost-sensitive markets.